Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study)
- PMID: 29535268
- PMCID: PMC5973804
- DOI: 10.1161/STROKEAHA.117.020059
Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study)
Abstract
Background and purpose: Emerging evidence suggests that an underlying atrial cardiopathy may result in thromboembolism before atrial fibrillation (AF) develops. We examined the association between various markers of atrial cardiopathy and the risk of ischemic stroke.
Methods: The CHS (Cardiovascular Health Study) prospectively enrolled community-dwelling adults ≥65 years of age. For this study, we excluded participants diagnosed with stroke or AF before baseline. Exposures were several markers of atrial cardiopathy: baseline P-wave terminal force in ECG lead V1, left atrial dimension on echocardiogram, and N terminal pro B type natriuretic peptide (NT-proBNP), as well as incident AF. Incident AF was ascertained from 12-lead electrocardiograms at annual study visits for the first decade after study enrollment and from inpatient and outpatient Medicare data throughout follow-up. The primary outcome was incident ischemic stroke. We used Cox proportional hazards models that included all 4 atrial cardiopathy markers along with adjustment for demographic characteristics and established vascular risk factors.
Results: Among 3723 participants who were free of stroke and AF at baseline and who had data on all atrial cardiopathy markers, 585 participants (15.7%) experienced an incident ischemic stroke during a median 12.9 years of follow-up. When all atrial cardiopathy markers were combined in 1 Cox model, we found significant associations with stroke for P-wave terminal force in ECG lead V1 (hazard ratio per 1000 μV*ms 1.04; 95% confidence interval, 1.001-1.08), log-transformed NT-proBNP (hazard ratio per doubling of NT-proBNP, 1.09; 95% confidence interval, 1.03-1.16), and incident AF (hazard ratio, 2.04; 95% confidence interval, 1.67-2.48) but not left atrial dimension (hazard ratio per cm, 0.96; 95% confidence interval, 0.84-1.10).
Conclusions: In addition to clinically apparent AF, other evidence of abnormal atrial substrate is associated with subsequent ischemic stroke. This finding is consistent with the hypothesis that thromboembolism from the left atrium may occur in the setting of several different manifestations of atrial disease.
Keywords: adult; atrial fibrillation; cardiomyopathies; risk factors; thromboembolism.
© 2018 American Heart Association, Inc.
Similar articles
-
Associations Between Atrial Cardiopathy and Cerebral Amyloid: The ARIC-PET Study.J Am Heart Assoc. 2020 Dec 15;9(24):e018399. doi: 10.1161/JAHA.120.018399. Epub 2020 Dec 8. J Am Heart Assoc. 2020. PMID: 33289449 Free PMC article.
-
History of Cancer and Atrial Cardiopathy: A Secondary Analysis of the ARCADIA Clinical Trial.J Am Heart Assoc. 2025 May 6;14(9):e040543. doi: 10.1161/JAHA.124.040543. Epub 2025 Apr 23. J Am Heart Assoc. 2025. PMID: 40265582 Free PMC article. Clinical Trial.
-
Atrial Cardiopathy and Cryptogenic Stroke: A Cross-sectional Pilot Study.J Stroke Cerebrovasc Dis. 2016 Jan;25(1):110-4. doi: 10.1016/j.jstrokecerebrovasdis.2015.09.001. Epub 2015 Oct 21. J Stroke Cerebrovasc Dis. 2016. PMID: 26476588 Free PMC article.
-
Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation.Future Cardiol. 2015 May;11(3):323-31. doi: 10.2217/fca.15.22. Future Cardiol. 2015. PMID: 26021638 Free PMC article. Review.
-
Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.Circulation. 2015 Jul 28;132(4):278-91. doi: 10.1161/CIRCULATIONAHA.115.016795. Circulation. 2015. PMID: 26216085 Free PMC article. Review.
Cited by
-
Association of Intracranial Hemorrhage Risk With Non-Vitamin K Antagonist Oral Anticoagulant Use vs Aspirin Use: A Systematic Review and Meta-analysis.JAMA Neurol. 2018 Dec 1;75(12):1511-1518. doi: 10.1001/jamaneurol.2018.2215. JAMA Neurol. 2018. PMID: 30105396 Free PMC article.
-
Prevalence of Nonstenotic Carotid Plaque in Stroke Due to Atrial Fibrillation Compared to Embolic Stroke of Undetermined Source.J Stroke Cerebrovasc Dis. 2019 Oct;28(10):104289. doi: 10.1016/j.jstrokecerebrovasdis.2019.07.005. Epub 2019 Jul 26. J Stroke Cerebrovasc Dis. 2019. PMID: 31353245 Free PMC article.
-
Association between excessive supraventricular ectopy and subclinical cerebrovascular disease: a population-based study.Eur J Neurol. 2019 Sep;26(9):1219-1225. doi: 10.1111/ene.13970. Epub 2019 May 9. Eur J Neurol. 2019. PMID: 31002446 Free PMC article.
-
Abnormal P-wave terminal force in lead V1 is a marker for atrial electrical dysfunction but not structural remodelling.ESC Heart Fail. 2021 Oct;8(5):4055-4066. doi: 10.1002/ehf2.13488. Epub 2021 Jun 30. ESC Heart Fail. 2021. PMID: 34196135 Free PMC article.
-
Impairment of left atrial function and cryptogenic stroke: Potential insights in the pathophysiology of stroke in the young.Int J Cardiol Heart Vasc. 2019 Dec 26;26:100454. doi: 10.1016/j.ijcha.2019.100454. eCollection 2020 Feb. Int J Cardiol Heart Vasc. 2019. PMID: 31909178 Free PMC article.
References
-
- Marnane M, Duggan CA, Sheehan OC, Merwick A, Hannon N, Curtin D, et al. Stroke subtype classification to mechanism-specific and undetermined categories by TOAST, A-S-C-O, and Causative Classification system. Stroke. 2010;41:1579–1586. - PubMed
-
- Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O’Donnell MJ, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13:429–438. - PubMed
-
- Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370:2478–2486. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials